Nucleus is a venture studio creating transformative brands and technologies that are reshaping mental healthcare for millions worldwide.
Backed by
Our ecosystem of companies spans data infrastructure, clinical tools, education platforms, and consumer wellness brands.
The data and technology hub powering the entire Nucleus ecosystem. Advanced analytics, patient management, and clinical intelligence for the psychedelic medicine industry.
Premier financial intelligence platform for the psychedelic sector. Market data, investment research, and industry analysis.
Marketing and brand acceleration studio helping psychedelic companies reach their audiences with precision.
Clinical trial management platform streamlining research operations for psychedelic medicine studies.
Education platform training the next generation of psychedelic practitioners and facilitators.
Smart AI platform for peptides, providing intelligent insights and personalized recommendations for wellness optimization.
We don't just invest. We build, operate, and scale companies that address critical gaps in the psychedelic medicine value chain.
We identify unmet needs in the industry and rapidly prototype solutions with embedded domain experts and clinicians.
Our in-house team of engineers, designers, and operators bring concepts to market with exceptional speed and quality.
Portfolio companies benefit from shared infrastructure, cross-promotion, and our extensive industry network.
Get exclusive updates on our portfolio companies, industry insights, and opportunities to participate in the psychedelic renaissance.